The GenusPlus share price has doubled in 12 months. We explore what’s driving the growth and why brokers are still bullish.

For those investors sailing the high seas for battered stocks that are undervalued, these ASX 200 shares fell more than 50% ...

The US Magnificent Seven stocks have lost significance, says Betashares senior investment strategist, Cameron Gleeson. Here's ...

These ASX ETFs could be worth a look if you have $10,000 to invest in the share market this month. Let's see what they ...

These two ASX value stocks offer investors great value, in my opinion. I think they’re two underrated S&P/ASX 300 Index (ASX: ...

Here's what you need to know about them: Catalyst Metals could be an ASX mining stock to buy according to the team at Morgans ...

According to the release, Pro Medicus will provide the ASX healthcare stock with $10 million via a facility agreement that includes security as collateral.

Investors are bidding up the S&P/ASX 200 Index (ASX: XJO) copper stock following its quarterly update. Here’s what you need to know.

The ResMed Inc (ASX: RMD) share price is on the move on Friday. This follows the release of the company's full year ...

In a quarter marred by tariff talk, iPhone sales were stronger than expected, and the company returned to growth in China.

Let's see what makes these ASX dividend shares potential no-brainer buys right now for income investors with $1,000 to put to ...

Monash IVF shares have had a rollercoaster journey this year following controversial incidents. Does Macquarie still rate them a buy?